Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No study data or content were changed.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:45.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updates: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:50:32.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T00:01:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision entry updated from v3.3.3 to v3.3.4; core study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-01-15T04:41:01.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - A consolidated Locations section was added listing study sites across Alabama, California, Georgia, New York, and Texas, with the previous state-specific location headings removed. The page revision was updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-24T15:16:36.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T14:46:44.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.